The COVID-19 pandemic: a threat to antimicrobial resistance containment

Future Sci OA. 2021 Jun 10;7(8):FSO736. doi: 10.2144/fsoa-2021-0012. eCollection 2021 Sep.

Abstract

As of 23 April 2021, the outbreak of COVID-19 claimed around 150 million confirmed cases with over 3 million deaths worldwide. Yet, an even more serious but silent pandemic, that of antimicrobial resistance (AMR), is likely complicating the outcome of COVID-19 patients. This study discusses the current knowledge on the emergence of the SARS-CoV-2 and highlights the likely contribution of the COVID-19 pandemic on the escalation of AMR. COVID-19 engenders extensive antibiotic overuse and misuse, and will undoubtedly and substantially increase AMR rates worldwide. Amid the expanding COVID-19 pandemic, policymakers should consider the hidden threat of AMR much more, which may well be enhanced through improper use of antibiotics to treat patients with severe COVID-19 infection.

Keywords: COVID-19 pandemic; COVID-19 vaccines; SARS-CoV-2; antimicrobial resistance; antimicrobial stewardship.

Publication types

  • Review